Compensated PTSD
Treatment Research Study
Treatment Research Study
Researchers at the Icahn School of Medicine at Mount Sinai are testing the use of Ketamine treatment and Written Exposure Therapy (WET) to alleviate the symptoms of PTSD.
Research Conducted in New York
Compensation is provided
Clinic visits
required
required
Symptoms of PTSD
18 - 70
Years Old
Years Old
Fast Facts
Study Background
Post-traumatic stress disorder (PTSD) is a chronic and disabling condition.
Currently available treatments for PTSD do not work for a significant proportion of individuals with this condition, or work only partially, leaving persistent and disabling residual symptoms.
Our researchers aim to find better treatments for those suffering from PTSD through the use of Ketamine infusions and Written Exposure Therapy (WET).
Join our study and participate at no cost.
Currently available treatments for PTSD do not work for a significant proportion of individuals with this condition, or work only partially, leaving persistent and disabling residual symptoms.
Our researchers aim to find better treatments for those suffering from PTSD through the use of Ketamine infusions and Written Exposure Therapy (WET).
Join our study and participate at no cost.
Additional Information
The purpose of the current study is to evaluate whether adding Written Exposure Therapy (WET) to a course of 6 ketamine infusions can maintain improvement in PTSD symptoms over a longer period of time, and whether these two treatments (ketamine and WET) can work better together.
You may be eligible to participate if you have PTSD and are 18-70 years old.
All eligible participants will receive a total of 6 ketamine infusions and 5 WET sessions; the combined treatment is administered over 3 consecutive weeks. All participants will be evaluated weekly until 12 weeks following the start of WET. During the course of the study, participants who are taking medication for psychiatric treatment will be asked not to make any changes to medication dosages, and not to start/stop any medication during this period.
Participants will be compensated for their time and participation in the study.
There is no cost to participate in this study.